Compare Amplitude Inc (AMPL) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amplitude Inc vs Novartis AG — how do they compare? Amplitude Inc trades at $12.78 (market cap $1.59B), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 185.8× Amplitude Inc's market cap, and Novartis AG pays a 3.07% dividend while Amplitude Inc pays none. Which is the better fit depends on your goals.
| AMPL | NVS | |
|---|---|---|
Market Cap | $1.59B | $295.37B |
Sector | Technology | Health |
52-Week High | $12.69 | $168.62 |
52-Week Low | $5.61 | $119.31 |
Enterprise Value | $1.45B | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amplitude Inc
Amplitude Inc is pioneering a new category of software called digital optimization. The company's digital optimization system serves as the command center for businesses to connect digital products to business outcomes.
Read more on AMPL →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
